SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Bharat Parenterals - Quaterly Results

12 Nov 2022 Evaluate
The sales for the September 2022 quarter moved up 35.60% to Rs. 819.00 millions as compared to Rs. 604.00 millions during the corresponding quarter last year.Net profit stood at Rs. 100.00  millions  compared to Rs. 80.20 millions in the corresponding previous quarter,high by 24.69%.Operating Profit saw a handsome growth to 157.40 millions from 126.40 millions in the quarter ended September 2022.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202209 202109 % Var 202209 202109 % Var 202203 202103 % Var
Sales 819.00 604.00 35.60 1079.90 1212.40 -10.93 2120.10 2036.70 4.09
Other Income 63.90 25.20 153.57 79.30 42.80 85.28 77.80 86.70 -10.27
PBIDT 157.40 126.40 24.53 192.10 251.00 -23.47 359.20 338.10 6.24
Interest 3.40 1.50 126.67 5.90 4.40 34.09 8.90 7.60 17.11
PBDT 154.00 124.90 23.30 186.20 246.60 -24.49 350.30 330.50 5.99
Depreciation 14.50 17.20 -15.70 29.90 34.60 -13.58 66.60 60.30 10.45
PBT 139.50 107.70 29.53 156.30 212.00 -26.27 283.70 270.20 5.00
TAX 39.50 27.50 43.64 43.80 54.20 -19.19 70.70 68.10 3.82
Deferred Tax 1.50 -1.30 -215.38 0.90 -2.60 -134.62 -9.40 -2.80 235.71
PAT 100.00 80.20 24.69 112.50 157.80 -28.71 213.00 202.10 5.39
Equity 57.70 57.30 0.70 57.70 57.30 0.70 57.70 57.30 0.70
PBIDTM(%) 19.22 20.93 -8.16 17.79 20.70 -14.08 16.94 16.60 2.06

Bharat Parenterals Share Price

1228.20 -33.00 (-2.62%)
23-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1679.85
Dr. Reddys Lab 1333.05
Cipla 1305.85
Zydus Lifesciences 947.10
Lupin 2340.20
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×